Resistance to antifolates in Plasmodium falciparum monitored by sequence analysis of dihydropteroate synthetase and dihydrofolate reductase alleles in a large number of field samples of diverse origins - PubMed (original) (raw)
doi: 10.1016/s0166-6851(97)00114-x.
C S Lee, R Bayoumi, A Djimde, O Doumbo, G Swedberg, L D Dao, H Mshinda, M Tanner, W M Watkins, P F Sims, J E Hyde
Affiliations
- PMID: 9364963
- DOI: 10.1016/s0166-6851(97)00114-x
Resistance to antifolates in Plasmodium falciparum monitored by sequence analysis of dihydropteroate synthetase and dihydrofolate reductase alleles in a large number of field samples of diverse origins
P Wang et al. Mol Biochem Parasitol. 1997 Nov.
Abstract
Resistance of Plasmodium falciparum to antifolate chemotherapy is a significant problem where combinations such as Fansidar (pyrimethamine-sulfadoxine; PYR-SDX) are used in the treatment of chloroquine-resistant malaria. Antifolate resistance has been associated with variant sequences of dihydrofolate reductase (DHFR) and dihydropteroate synthetase (DHPS), the targets of PYR and SDX respectively. However, while the nature and distribution of mutations in the dhfr gene are well established, this is not yet the case for dhps. We have thus examined by DNA sequence analysis 141 field samples from several geographical regions with differing Fansidar usage (West and East Africa, the Middle East and Viet Nam) to establish a database of the frequency and repertoire of dhps mutations, which were found in 60% of the samples. We have also simultaneously determined from all samples their dhfr sequences, to better understand the relationship of both types of mutation to Fansidar resistance. Whilst the distribution of mutations was quite different across the regions surveyed, it broadly mirrored our understanding of relative Fansidar usage. In samples taken from individual patients before and after drug treatment, we found an association between the more highly mutated forms of dhps and/or dhfr and parasites that were not cleared by antifolate therapy. We also report a novel mutation in a Pakistani sample at position 16 of DHFR (A16S) that is combined with the familiar C59R mutation, but is wild-type at position 108. This is the first observation in a field sample of a mutant dhfr allele where the 108 codon is unchanged.
Similar articles
- High prevalence of quintuple mutant dhps/dhfr genes in Plasmodium falciparum infections seven years after introduction of sulfadoxine and pyrimethamine as first line treatment in Malawi.
Bwijo B, Kaneko A, Takechi M, Zungu IL, Moriyama Y, Lum JK, Tsukahara T, Mita T, Takahashi N, Bergqvist Y, Björkman A, Kobayakawa T. Bwijo B, et al. Acta Trop. 2003 Mar;85(3):363-73. doi: 10.1016/s0001-706x(02)00264-4. Acta Trop. 2003. PMID: 12659974 - Mutations in Plasmodium falciparum dihydrofolate reductase and dihydropteroate synthase and epidemiologic patterns of pyrimethamine-sulfadoxine use and resistance.
Plowe CV, Cortese JF, Djimde A, Nwanyanwu OC, Watkins WM, Winstanley PA, Estrada-Franco JG, Mollinedo RE, Avila JC, Cespedes JL, Carter D, Doumbo OK. Plowe CV, et al. J Infect Dis. 1997 Dec;176(6):1590-6. doi: 10.1086/514159. J Infect Dis. 1997. PMID: 9395372 - Antifolates can have a role in the treatment of Plasmodium vivax.
Hawkins VN, Joshi H, Rungsihirunrat K, Na-Bangchang K, Sibley CH. Hawkins VN, et al. Trends Parasitol. 2007 May;23(5):213-22. doi: 10.1016/j.pt.2007.03.002. Epub 2007 Mar 26. Trends Parasitol. 2007. PMID: 17368986 Review.
Cited by
- High multiple mutations of Plasmodium falciparum-resistant genotypes to sulphadoxine-pyrimethamine in Lagos, Nigeria.
Quan H, Igbasi U, Oyibo W, Omilabu S, Chen SB, Shen HM, Okolie C, Chen JH, Zhou XN. Quan H, et al. Infect Dis Poverty. 2020 Jul 11;9(1):91. doi: 10.1186/s40249-020-00712-4. Infect Dis Poverty. 2020. PMID: 32653033 Free PMC article. - Similar trends of pyrimethamine resistance-associated mutations in Plasmodium vivax and P. falciparum.
Alam MT, Bora H, Bharti PK, Saifi MA, Das MK, Dev V, Kumar A, Singh N, Dash AP, Das B, Wajihullah, Sharma YD. Alam MT, et al. Antimicrob Agents Chemother. 2007 Mar;51(3):857-63. doi: 10.1128/AAC.01200-06. Epub 2006 Dec 28. Antimicrob Agents Chemother. 2007. PMID: 17194833 Free PMC article. - Prevalence of mutations associated with higher levels of sulfadoxine-pyrimethamine resistance in Plasmodium falciparum isolates from Car Nicobar Island and Assam, India.
Ahmed A, Lumb V, Das MK, Dev V, Wajihullah, Sharma YD. Ahmed A, et al. Antimicrob Agents Chemother. 2006 Nov;50(11):3934-8. doi: 10.1128/AAC.00732-06. Epub 2006 Sep 18. Antimicrob Agents Chemother. 2006. PMID: 16982787 Free PMC article. - The Structural and Functional Basis for Recurring Sulfa Drug Resistance Mutations in Staphylococcus aureus Dihydropteroate Synthase.
Griffith EC, Wallace MJ, Wu Y, Kumar G, Gajewski S, Jackson P, Phelps GA, Zheng Z, Rock CO, Lee RE, White SW. Griffith EC, et al. Front Microbiol. 2018 Jul 17;9:1369. doi: 10.3389/fmicb.2018.01369. eCollection 2018. Front Microbiol. 2018. PMID: 30065703 Free PMC article.